Medication-info.com Search Menu

Ryaltris: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
665 mcg, 25 mcg
Active ingredients:

Patient information: uses, side effects, how to take - Ryaltris

What is RYALTRIS?

RYALTRIS is a prescription nasal spray that contains 2 medicines, olopatadine hydrochloride, an antihistamine, and mometasone furoate, a corticosteroid. RYALTRIS is used to treat symptoms of seasonal allergies in people 6 years of age and older.

It is not known if RYALTRIS is safe and effective in children under 6 years of age.

Do not use RYALTRIS if you are allergic to olopatadine hydrochloride, mometasone furoate monohydrate, or any of the ingredients in RYALTRIS. See the end of this Patient Information leaflet for a complete list of ingredients in RYALTRIS. Ask your healthcare provider if you are not sure.

Before you use RYALTRIS, tell your healthcare provider about all of your medical conditions, including if you:

  • have had recent nasal sores, nasal surgery, or nasal injury.
  • have eye or vision problems, such as cataracts or glaucoma (increased pressure in your eyes).
  • have tuberculosis or any untreated fungal, bacterial, viral infections, or eye infections caused by herpes.
  • have been near someone who has chickenpox or measles.
  • are not feeling well or have any other symptoms that you do not understand.
  • are pregnant or plan to become pregnant. It is not known if RYALTRIS will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.

  • are breastfeeding or plan to breastfeed. It is not known if RYALTRIS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while using RYALTRIS.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Especially tell your healthcare provider if you take:

  • certain medicines for HIV (such as ritonavir, atazanavir, indinavir, nelfinavir, and saquinavir)
  • cobicistat-containing products
  • certain antifungals (such as ketoconazole or itraconazole)
  • certain antibiotics (such as clarithromycin and telithromycin)
  • certain antidepressants (such as nefazodone)

RYALTRIS and other medicines may affect each other, causing side effects.

Know the medicines you take. Keep a list of your medicines and show it to your healthcare provider or pharmacist when you get a new medicine.

How should I use RYALTRIS?

  • Read the Instructions for Use at the end of this Patient Information leaflet for information about the right way to use RYALTRIS.
  • RYALTRIS is for use in your nose only. Do not spray it into your eyes or mouth.
  • Use RYALTRIS exactly as your healthcare provider tells you to use it.
  • If a child accidentally swallows RYALTRIS or you use too much RYALTRIS, call your healthcare provider or go to the nearest hospital emergency room right away.
  • See your healthcare provider regularly to check your symptoms while using RYALTRIS and to check for side effects.

What should I avoid while using RYALTRIS?

  • RYALTRIS can cause sleepiness or drowsiness. Do not drive, operate machinery, or do anything that needs you to be alert until you know how RYALTRIS affects you.
  • Do not drink alcohol or take any other medicines that may cause you to feel sleepy while using RYALTRIS.

What are the possible side effects of RYALTRIS?

RYALTRIS may cause serious side effects, including the following:

  • nose and throat problems. Symptoms of nose and throat problems may include:

    • nosebleeds
    • sores (ulcers) in the nose
    • hole in the cartilage between your nose (nasal septal perforation). Symptoms of nasal septal perforation may include:

      • crusting in the nose
      • nosebleeds
      • runny nose
      • whistling sound when you breathe
    • slow wound healing. You should not use RYALTRIS until your nose has healed if you have a sore in your nose, if you have had surgery on your nose, or if your nose has been injured.
    • thrush (Candida), a certain fungal infection in your nose and throat. Tell your healthcare provider if you have any redness or white-colored patches in your nose or mouth.
  • sleepiness or drowsiness.
  • eye problems, including glaucoma or cataracts. You should have regular eye exams when using RYALTRIS.
  • allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following signs of a serious allergic reaction:
  • wheezing
  • rash
  • hives
  • swelling of your face, mouth, and tongue
  • breathing problems
  • immune system problems that may increase your risk of infections. Taking medicines that weaken your immune system makes you more likely to get infections. These infections may include tuberculosis (TB), ocular herpes simplex infections, and infections caused by fungi, bacteria, viruses, and parasites. Avoid contact with people who have contagious diseases, such as chickenpox or measles, while using RYALTRIS. If you come in contact with someone who has chicken pox or measles call your healthcare provider right away. Symptoms of infection may include:
  • fever
  • aches or pains
  • chills
  • feeling tired
  • adrenal insufficiency. Adrenal insufficiency happens when your adrenal glands do not make enough steroid hormones. Symptoms of adrenal insufficiency can include:
  • tiredness
  • weakness
  • nausea
  • vomiting
  • low blood pressure
  • slowed growth in children. A child’s growth should be checked regularly while using RYALTRIS.

The most common side effects of RYALTRIS include:

  • unpleasant taste
  • nosebleeds
  • nasal discomfort
  • headache

Tell your healthcare provider if you have any side effects that bother you or that do not go away. These are not all of the possible side effects of RYALTRIS. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088.

How should I store RYALTRIS?

  • Store RYALTRIS upright with the purple dust cap on at room temperature between 68°F to 77°F (20°C to 25°C).
  • Do not freeze or refrigerate.
  • Safely throw away medicine that is out of date or no longer needed.
  • Throw away your RYALTRIS 240 metered sprays bottle after using 240 sprays after the first priming. Even though the bottle may not be completely empty, you may not get the correct dose of medicine if you continue to use it.

Keep RYALTRIS and all medicines out of reach of children.

General information about the safe and effective use of RYALTRIS

Medicines are sometimes prescribed for purposes other than those listed in the Patient Information. Do not use RYALTRIS for a condition for which it was not prescribed. Do not give RYALTRIS to other people, even if they have the same symptoms that you have. It may harm them.

You can ask your healthcare provider or pharmacist for information about RYALTRIS that is written for health professionals.

What are the ingredients in RYALTRIS?

Active ingredients: olopatadine hydrochloride and mometasone furoate monohydrate

Inactive ingredients: benzalkonium chloride, carboxymethyl cellulose sodium, dibasic sodium phosphate heptahydrate, edetate disodium, hydrochloric acid, microcrystalline cellulose, glycerin, polysorbate 80, sodium chloride, sodium hydroxide, and water.

For more information, go to www.RYALTRIS.com or call Glenmark Pharmaceuticals Inc., USA at 1 (888) 721-7115.

This Patient Information has been approved by the U.S. Food and Drug Administration

  • Revised: July 2026

INSTRUCTIONS FOR USE

RYALTRIS (rye - al’ - tris)

(olopatadine hydrochloride and mometasone furoate monohydrate nasal spray)

Important: For use in your nose only. Do not spray RYALTRIS into your eyes or mouth.

Read the Instructions for Use before you start to use RYALTRIS and each time you get a refill. There may be new information. This Instructions for Use does not take the place of talking with your healthcare provider about your medical condition or treatment. Before you use RYALTRIS, make sure your healthcare provider shows you the right way to use it.

Shake the bottle for at least 10 seconds before each use.

When RYALTRIS is not in use, the purple dust cap should always be kept tightly placed on the spray nozzle tip.

Your RYALTRIS nasal spray bottle (See Figure A)

Figure A

Preparing the nasal spray bottle

Before you prime the bottle, shake the bottle for at least 10 seconds.

Before first use, spray the product 6 times or until a fine mist appears. Spray away from your eyes and face.

Step 1. Remove the purple dust cap from the spray nozzle tip of the bottle. (See Figure B)

Figure B

Step 2. Hold the nasal spray bottle firmly and upright with your index and middle finger on either side of the spray nozzle unit (on finger rests) while supporting the grooved base of the bottle with your thumb.

Step 3. Before first use, push down on the pump quickly and firmly 6 times, releasing the spray into the air, away from the eyes and face until a fine mist appears. (See Figure C)

Figure C

If you do not use RYALTRIS for 14 or more days, you will need to shake the bottle for at least 10 seconds, and prime the pump with 2 sprays or until a fine mist appears.

Your RYALTRIS is now ready for use.

Using your RYALTRIS

Step 4.

Gently blow your nose to clear your nostrils. (See Figure D)

Figure D

Step 5. Shake the bottle for at least 10 seconds before each use (morning and evening).

Step 6. Hold the bottle firmly with your index and middle finger on either side of the spray nozzle unit (on finger rests) while supporting the grooved base of the bottle with your thumb. (See Figure E)

Figure E

Step 7. Hold 1 nostril closed with a finger. Insert the end of the spray nozzle tip into the other nostril, pointing it slightly toward the outside of the nose, away from the nasal septum (the wall between the 2 nostrils). (See Figure F)

Figure F

Step 8. Tilt your head forward slightly. Keep the bottle upright and press down one time quickly and firmly on the finger rests to activate the pump. (See Figure G) Breathe in (inhale) gently through your nose as you spray. Then breathe out through your mouth.

Figure G

  • Try not to get any spray into your eyes or directly on your nasal septum (the wall between the 2 nostrils).

Step 9. Repeat Steps 6 through 8 and deliver a second spray in the same nostril.

Step 10. Repeat Steps 6 through 8 with 2 sprays in the other nostril.

  • Do not blow your nose for at least 15 minutes after using RYALTRIS, to make sure that you receive all of the medicine.
  • Do not tip your head back. This will keep the medicine from going into your throat.

Step 11. To prevent any blockage, wipe the spray nozzle tip with a clean dry tissue or cloth after each use. (See Figure H)

Figure H

Step 12. Hold the nozzle unit and push the purple dust cap back on the nozzle until you hear a click. (See Figure I)

Figure I

Each bottle of RYALTRIS 240 metered sprays contains enough medicine for you to spray from the bottle 240 times after the first (initial) priming. You should keep track of the number of sprays used from each bottle of RYALTRIS. Do not count any sprays used for initial priming of the bottle.

How to clear the RYALTRIS nozzle tip if it gets blocked

Do not try to unblock the spray nozzle tip by inserting a pin or other sharp object. (See Figure J) This will damage the spray nozzle tip, and you may not get the correct dose of medicine.

Figure J

Step 13. Remove the spray nozzle unit by gently pulling upward (See Figure K). Remove the purple dust cap and place only the spray nozzle unit in warm water to soak. (See Figure L)

Figure K

Figure L

Step 14. After soaking the spray nozzle tip for 15 minutes, rinse the spray nozzle unit and purple dust cap with warm water and allow them to dry completely. (See Figure M)

Figure M

Step 15. Place the purple dust cap back on the spray nozzle unit and put the spray nozzle unit back on the bottle. (See Figure N)

Figure N

Step 16. After following the steps to clear your blocked spray nozzle tip see “Preparing the nasal spray bottle” section above and re-prime using 2 sprays. Replace the purple dust cap, and your RYALTRIS is ready for use.

Repeat the unblocking steps if needed.

How should I store RYALTRIS?

Store RYALTRIS at room temperature between 68°F to 77°F (20°C to 25°C).

Do not freeze or refrigerate.

Do not use RYALTRIS after the expiration date on the label or the box.

Throw away your RYALTRIS 240 metered sprays bottle after using 240 sprays after first priming. Even though the bottle may not be completely empty, you may not get the correct dose of medicine if you continue to use it.

Keep RYALTRIS and all medicines out of the reach of children.

Distributed by:

Glenmark Pharmaceuticals Inc., USA

Elmwood Park, NJ 07407

RYALTRIS and the RYALTRIS logo are registered trademarks of Glenmark Specialty SA

  • This Instructions for Use has been approved by the U.S. Food and Drug Administration. Revised: July 2026

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 211746 · View the label on DailyMed

Revision date stated in the text: July 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ryaltris

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Corticosteroid, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer
Active ingredients Olopatadine hydrochloride 665 mcg, Mometasone furoate monohydrate 25 mcg
Dosage form Spray, metered
Route Nasal
Marketing status listed in the FDA NDC Directory
Company (applicant) GLENMARK SPECLT
FDA approval NDA 211746New Drug Application (NDA) Approved January 13, 2022
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 2 labelers list this drug on DailyMed
Packages (NDC)
Package
665 mcg, 25 mcg – 240 in 1 bottle, spray / 1 in 1 carton / 12 in 1 box NDC 68462-659-27
665 mcg, 25 mcg – 56 in 1 bottle, spray / 1 in 1 carton / 12 in 1 box NDC 68462-659-84

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.